Wells Fargo
PMN icon

Wells Fargo’s ProMIS Neurosciences PMN Stock Holding History

Wells Fargo’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$30 – 7034
2024
Q2 		$30 Buy
+1
New +$47 ﹤0.01% 6425

Other funds holding PMN

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return

Wells Fargo's PMN Position: Q3 2024 in Review

Wells Fargo sold out of ProMIS Neurosciences (PMN) in Q3 2024, closing a stake of 1 share — an estimated $30 sold.

Wells Fargo first reported a position in PMN in Q2 2024 and held it in 1 quarter. The position peaked at $30 in Q2 2024. 17 funds tracked by Wall St. Rank hold PMN as of Q3 2024.

  • Wells Fargo reported no remaining ProMIS Neurosciences position as of Q3 2024 after selling out during the quarter.
  • Wells Fargo sold 1 ProMIS Neurosciences share in Q3 2024, an estimated $30.
  • Wells Fargo first reported a position in ProMIS Neurosciences in Q2 2024 and held it in 1 quarter.
  • Wells Fargo's ProMIS Neurosciences position peaked at $30 in Q2 2024.
  • 17 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2024.

Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.